Health Policy & Disability Benefits
Health Care Costs Remain Top Financial Worry for U.S. Families, Spurring Widespread Delays in Care and Medical Debt
For many years, ongoing polling from KFF has documented how the high cost of health care serves as a profound...
Nebraska Pioneers Medicaid Work Requirements: Early Implementation Data Reveal Mixed Outcomes for Applicants and Enrollees
On May 1, 2026, Nebraska officially became the first state in the nation to enforce new Medicaid work requirements, marking...
Healthcare at a Crossroads: Industry Leaders Urge Proactive Oversight as AI Agents Penetrate Medical Systems
As artificial intelligence rapidly transitions from a futuristic concept into the operational backbone of modern hospitals and healthcare networks, the...
PEPFAR Faces Mixed Performance and Data Gaps Following Trump Administration Overhaul, Analysis Finds
Since the inauguration of the second Trump administration, the President’s Emergency Plan for AIDS Relief (PEPFAR)—the landmark U.S. global HIV/AIDS...
Federal Oversight Intensifies as Medicaid Fraud Control Units Face Rigorous Scrutiny and Funding Cuts
Federal law mandates that every U.S. state operate a dedicated Medicaid Fraud Control Unit (MFCU) tasked with investigating and prosecuting...
Millions in the U.S. Face Severe Health Care and Coverage Gaps Due to Language Barriers, New Analysis Finds
Introduction As of 2024, approximately 28.5 million individuals aged five and older across the United States live with limited English...
Joe Grogan Warns Against the Wrong Kind of Regulation for Artificial Intelligence in Health Care
As the technology sector continues to grapple with the rapid acceleration of artificial intelligence, a prominent debate has emerged around...
Navigating the Digital Health Landscape: Trust, Misinformation, and AI Governance in 2026
VOLUME 55 September 24, 2026 Highlights The shifting dynamics of public health in the digital age continue to pose complex...
New KFF Analysis Finds TrumpRx Brand-Name Drug Prices Often Equal to Other Wealthy Nations
Consumers purchasing brand-name prescription drugs without an available generic or biosimilar through the newly launched TrumpRx website face a financial...
TrumpRx Brand-Name Drug Prices Show Mixed Results Compared to Other Wealthy Nations, Analysis Finds
WASHINGTON — Prices for brand-name medications available through TrumpRx are roughly as likely to be higher as they are to...